Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL

Authors

Zaid Al-Kadhimi, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA. zaid.alkadhimi@unmc.edu.
Samuel Pirruccello, Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
Zartash Gul, Advocate Aurora HealthFollow
Lori Maness-Harris, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Vijaya Raj Bhatt, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Krishna Gundabolu, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Jane Yuan, Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, NY, USA.
Matthew Lunning, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Gregory Bociek, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Christopher D'Angelo, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Avyakta Kallam, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
James Armitage, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Khansa Abdullah, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Angela Hunter, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Sarah Mccaslin, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Elizabeth Lyden, Division of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Lynnette Smith, Division of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Michael Callahan, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
Kathryn Cole, Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
Steven Hinrichs, Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
James Talmadge, Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
Julie Vose, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.

Recommended Citation

Al-Kadhimi Z, Pirruccello S, Gul Z, et al. Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL. Bone Marrow Transplant. 2022;57(10):1629-1631. doi:10.1038/s41409-022-01772-w

Type

Letter

PubMed ID

35953707